STOCK TITAN

Vericel Corp (VCEL) officer exercises options and sells 4,500 shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Vericel Corp Principal Accounting Officer Jonathan Siegal exercised stock options covering 4,500 shares of common stock on July 30, 2026 at exercise prices of $34.90 and $29.82 per share, then sold 4,500 shares at $48.90 per share under an automatic Rule 10b5-1 trading plan adopted on December 10, 2025.

Positive

  • None.

Negative

  • None.
Insider SIEGAL JONATHAN
Role Principal Accounting Officer
Sold 4,500 shs ($220K)
Approx. gross sale proceeds $220K
Approx. exercise cost $142K
Approx. pre-tax spread $78K
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F3 1,500 $0.00 $0.00
Exercise Stock Option (Right to Buy) F4 2,500 $0.00 $0.00
Exercise Stock Option (Right to Buy) F4 500 $0.00 $0.00
Exercise Common Stock F1 1,500 $34.90 $52K
Sale Common Stock F2, F1 1,500 $48.90 $73K
Exercise Common Stock F1 2,500 $29.82 $75K
Sale Common Stock F2, F1 2,500 $48.90 $122K
Exercise Common Stock F1 500 $29.82 $15K
Sale Common Stock F2, F1 500 $48.90 $24K
Holdings After Transaction: Stock Option (Right to Buy) — 10,198 shares (Direct); Common Stock — 1,078 shares (Direct)
Footnotes (4)
  1. F1. These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  2. F2. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.
  3. F3. These options, representing the right to purchase 4,198 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 18, 2022, which was one quarter after the date on which the option was granted
  4. F4. These options, representing the right to purchase 9,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted.
Shares sold 4,500 shares Total Vericel common shares sold by Jonathan Siegal on July 30, 2026
Shares exercised 4,500 shares Total shares underlying stock options exercised on July 30, 2026
Option exercise price 1 $34.90 per share Exercise price for 1,500 Vericel shares obtained via stock options
Option exercise price 2 $29.82 per share Exercise price for 3,000 Vericel shares obtained via stock options
Sale price $48.90 per share Price at which 4,500 Vericel common shares were sold
Rule 10b5-1 plan adoption December 10, 2025 Adoption date of the trading plan governing the reported sales
Option grant size 1 4,198 shares Shares covered by one option grant vesting quarterly from May 18, 2022
Option grant size 2 9,000 shares Shares covered by another option grant vesting quarterly from May 17, 2023
Rule 10b5-1 trading plan regulatory
"The sales were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Employee Stock Purchase Plan financial
"shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy) with underlying Common Stock"
Rule 16b-3(d) regulatory
"transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)"
Rule 16b-3(d) is a narrow SEC safe-harbor that shields company insiders (officers, directors and large shareholders) from liability for short‑swing profits when their buys or sells of company stock are made under a pre-established, written plan or contract that removes the insider’s ability to time trades. For investors, this matters because it permits predictable, automated insider transactions — like scheduled sales for diversification or payroll withholding — without triggering forced disgorgement, so such planned trades are treated differently from opportunistic insider trading.
Rule 16b-3(c) regulatory
"transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)"
An SEC rule that lets corporate insiders avoid automatic "short‑swing" profit recovery when they buy or sell their company’s stock under a pre‑approved, written plan that meets specific conditions. For investors, it matters because it clarifies when insider trades are treated as routine, reducing legal uncertainty and helping distinguish trades made for ordinary compensation or pre‑planned reasons from those that might signal opportunistic or timely insider advantage.
Principal Accounting Officer financial
"reporting person is an officer with title Principal Accounting Officer"
The Principal Accounting Officer is the person responsible for making sure a company's financial records are accurate and follow the rules. They play a key role in preparing financial reports that show how well the company is doing. This helps investors, managers, and regulators trust the company's financial information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider trading activity did Vericel (VCEL) officer Jonathan Siegal report?

Jonathan Siegal exercised stock options for 4,500 Vericel shares and sold 4,500 shares on July 30, 2026. The options had exercise prices of $34.90 and $29.82 per share, while the shares were sold at $48.90 per share.

How many Vericel (VCEL) shares did Jonathan Siegal sell and at what price?

Jonathan Siegal sold 4,500 shares of Vericel common stock at $48.90 per share. These sales occurred on July 30, 2026 and followed same-day option exercises that generated an equivalent number of shares of Vericel common stock.

Were Jonathan Siegal’s Vericel (VCEL) share sales made under a Rule 10b5-1 plan?

Yes. The sales were effected automatically under a Rule 10b5-1 trading plan. The plan was adopted by Jonathan Siegal on December 10, 2025, and the report affirms that the reported transactions were conducted pursuant to this pre-arranged trading plan.

What Vericel (VCEL) stock options did Jonathan Siegal exercise?

Jonathan Siegal exercised options covering 4,500 shares of Vericel common stock at exercise prices of $34.90 and $29.82 per share. The options come from grants originally representing rights to purchase 4,198 and 9,000 shares that vested quarterly, contingent on continued service.

What is Jonathan Siegal’s position at Vericel (VCEL)?

Jonathan Siegal serves as Vericel’s Principal Accounting Officer. His reported transactions involve exercises of Vericel stock options and subsequent sales of common shares, all reported as directly owned and conducted under a Rule 10b5-1 trading plan structure.

Did the Vericel (VCEL) report indicate any tax-withholding share dispositions?

No tax-withholding dispositions were reported; there were no transactions coded for tax liability. The activity consisted of option exercises (code M) covering 4,500 shares and open-market sales (code S) of 4,500 shares of Vericel common stock.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SIEGAL JONATHAN

(Last)(First)(Middle)
25 BLUE SKY DRIVE

(Street)
BURLINGTON MASSACHUSETTS 01803

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Vericel Corp [ VCEL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Principal Accounting Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/30/2026M1,500A$34.92,578(1)D
Common Stock07/30/2026S1,500D(2)$48.91,078(1)D
Common Stock07/30/2026M2,500A$29.823,578(1)D
Common Stock07/30/2026S2,500D(2)$48.91,078(1)D
Common Stock07/30/2026M500A$29.821,578(1)D
Common Stock07/30/2026S500D(2)$48.91,078(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$34.907/30/2026M1,500 (3)02/18/2032Common Stock1,500$02,698D
Stock Option (Right to Buy)$29.8207/30/2026M2,500 (4)02/17/2033Common Stock2,500$04,000D
Stock Option (Right to Buy)$29.8207/30/2026M500 (4)02/17/2033Common Stock500$03,500D
Explanation of Responses:
1. These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
2. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.
3. These options, representing the right to purchase 4,198 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 18, 2022, which was one quarter after the date on which the option was granted
4. These options, representing the right to purchase 9,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted.
/s/ Sean Flynn, as Attorney-in-Fact for Jonathan Siegal07/31/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)